Skip to content

Comparison of vaginal misoprostol and intra cervical foleycatheter for cervical ripening

Comparison of vaginal misoprostol and intra cervical foleycatheter for cervical ripening of postdate primigravid women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181218042033N4
Enrollment
120
Registered
2020-04-19
Start date
2017-08-15
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous delivery. Encounter for full-term uncomplicated delivery

Interventions

Intervention 1: Intervention group: vaginal misoprostol 25 microgram. Intervention 2: Intervention group: cervical foley catheter.

Sponsors

Bandare-abbas University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Primigravid women 18-35 yeares old Vaginal bleeding Abnormal fetal heartbeat Natural disease that needed to terminate the pregnancy season

Exclusion criteria

Exclusion criteria: Misoprostol susceptibility Uterine scar

Design outcomes

Primary

MeasureTime frame
Cervical dilatation. Timepoint: Every 6 hours. Method of measurement: Vaginal examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForoogh Pakbaz

Bandare-abbas University of Medical Sciences

forooghpakbaz@gmail.com+98 76 3647 9830

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 22, 2026